RenovoRx joins JonesTrading webinar on TAMP platform in pancreatic cancer

• RenovoRx will join a JonesTrading virtual key opinion leader webinar on Aug. 13, 2026 at 1:30 p.m. ET.
• Discussion will center on the TAMP drug-delivery platform, RenovoCath commercialization, and the Phase III TIGeR-PaC pancreatic cancer trial.
• CEO Shaun Bagai will participate alongside clinicians from Moffitt Cancer Center and AdventHealth Cancer Institute.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608040830PRIMZONEFULLFEED9802735) on August 04, 2026, and is solely responsible for the information contained therein.